Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

3 Resultados de la búsqueda.

Eligibility Disease Burden of Pathients with Incurable Cancer Disease DRKS00007536 NCT02751723 DRKS00007536 - Eligibility Disease Burden of Pathients with Incurable Cancer Disease NCT02751723 DRKS00007536

- 22/6/17 - 1 formulario, 2 itemgroups, 6 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Responsible Party: Florian Lordick, MD, Prof. Dr. med. (MD, PhD), University of Leipzig ClinicalTrials.gov Identifier: NCT02751723 History of Changes Other Study ID Numbers: APM Project DRKS00007536 ( Registry Identifier: Deutsches Register Klinischer Studien ) Study First Received: April 14, 2016 Last Updated: May 6, 2017 Individual Participant Data Plan to Share IPD: No Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease (APM-Project) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02751723

Eligibility Hepatocellular Carcinoma NCT01935700

- 27/9/21 - 1 formulario, 2 itemgroups, 14 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01935700

Eligibility Hepatocellular Carcinoma NCT00923897

- 20/4/18 - 1 formulario, 2 itemgroups, 9 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4); ODM derived from: https://clinicaltrials.gov/show/NCT00923897

Utilice este formulario para comentarios, preguntas y sugerencias.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.